Skip to main content

Day: March 2, 2021

Genocea to Present at the H.C. Wainwright Global Life Sciences Conference

CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference being held from March 9-10, 2021. A webcast of the on-demand presentation will be available on the investor section of the Genocea website at http://ir.genocea.com, beginning on Tuesday, March 9, 2021 at 7:00 A.M. ET.Following the conclusion of the conference, the presentation will remain archived on the Genocea website for approximately 90 days.About Genocea Biosciences, Inc.Genocea’s mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our proprietary...

Continue reading

NexImmune to Present at the 2021 Barclays Global Healthcare Conference

GAITHERSBURG, Md., March 02, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Scott Carmer, Chief Executive Officer, will present a company overview at the virtual 2021 Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 10:55 a.m. Eastern time.The presentation will be accessible via live webcast by visiting https://ir.neximmune.com/investors/events-and-presentations. A replay will be available on the NexImmune website following the presentation.About NexImmuneNexImmune, based in Gaithersburg, Maryland, is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed...

Continue reading

Passage Bio to Participate in Upcoming March Investor Conferences

PHILADELPHIA, March 02, 2021 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will participate in two upcoming virtual investor conferences in March:Barclay’s Global Healthcare ConferenceFormat: PresentationDate: Wednesday, March 10, 2021Time: 4:10 p.m. ETStifel 3rdAnnual CNS DayFormat: Fireside ChatDate: Wednesday, March 31, 2021Time: 10:00 a.m. ETA live webcast of the presentation and fireside chat will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the Barclay’s and Stifel presentations will be available for 30 days following the fireside chat.About Passage BioAt Passage Bio (Nasdaq: PASG),...

Continue reading

Big 5 Sporting Goods Corporation Announces Fiscal 2020 Fourth Quarter and Full Year Results

FY 2020 Full Year EPS of $2.58FY 2020 Fourth Quarter EPS of $0.95Ends FY 2020 with $64.7 Million in Cash and Cash Equivalents, No DebtIncreases Quarterly Cash Dividend 50% to $0.15 per ShareEL SEGUNDO, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Big 5 Sporting Goods Corporation (Nasdaq: BGFV) (the “Company,” “we,” “our,” “us,” “Big 5”), a leading sporting goods retailer, today reported financial results for the fiscal 2020 fourth quarter and full year ended January 3, 2021.Steven G. Miller, the Company’s Chairman, President and Chief Executive Officer, said, “Our strong fourth quarter results highlight our exceptional performance in fiscal 2020 with record earnings driven by top line sales growth, merchandise margin expansion and an improved cost structure. As we faced the many challenges of 2020, we remained focused on providing...

Continue reading

Eargo Finds the Sounds Americans Miss Most During the Pandemic

SAN JOSE, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Eargo, Inc. (Nasdaq: EAR) a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the results of its World Hearing Day survey, in celebration of World Hearing Day on March 3.The survey of 2,000 Americans uncovers how people ages 40 and older are faring during the pandemic, exploring their connection to the world and to their friends and family. The findings suggest that Americans are optimistic about the future, and that hearing will play a vital role in reconnecting with “normal” in the coming months.“On World Hearing Day we want to shine a light on hearing and hearing loss,” said Eargo CEO Christian Gormsen. “The CDC says hearing loss is the third most common chronic physical condition in the United States, and there...

Continue reading

Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results

REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year of 2020 ended December 31, 2020.Recent HighlightsAchieved full year 2020 worldwide revenue of $32.7M, including 51% year-over-year sales growth in the U.S. despite challenges posed by the pandemicExpanded base of U.S. treatment centers for Zephyr Valve by over 50% since the start of 2020Increased the number of U.S. sales representatives by over 40% since the start of the 2020“In closing out 2020, we are encouraged by the demonstrable resilience of our business and underlying demand for the Zephyr Valve. Although we faced headwinds from COVID-19 through the fourth...

Continue reading

FedNat Holding Company Reports Fourth Quarter and Full Year 2020 Results

SUNRISE, Fla., March 02, 2021 (GLOBE NEWSWIRE) — FedNat Holding Company (the “Company”) (Nasdaq: FNHC) today reported results for the three and twelve months ended December 31, 2020.Q4 2020 highlights (as measured against the same three-month period last year, except where noted):Net loss of $32.9 million or $2.40 per diluted shareAdjusted operating loss of $26.9 million or $1.96 per diluted share.$31.1 million, pre-tax, net of recoveries, of claims related to Hurricanes Delta, Zeta and Eta, which together impacted portions of Texas, Florida, Louisiana and Alabama, as previously communicated.$11.5 million, pre-tax, prior year reserve development, due primarily to $16.5 million of reserve strengthening in the discontinued commercial general liability line of business, partially offset by $5.0 million of reserve redundancy in our...

Continue reading

Kforce Announces Its Participation in Two March 2021 Investor Conferences

TAMPA, Fla., March 02, 2021 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC) is scheduled to participate in the following upcoming conferences:2021 Truist Securities Technology, Internet & Services Conference on March 9-10, 2021.Sidoti Virtual Investor Conference on March 25, 2021. The live conference webcast will take place at 8:30 a.m. ET  A link to the live conference webcast and presentation can be accessed on Kforce’s web site at www.kforce.com in the Investor Relations section under “Events and Presentations.”About KforceKforce Inc. is a domestic professional staffing services and solutions firm that specializes in the areas of Technology and Finance and Accounting. Each year, through our network of field offices located throughout the U.S. and two national delivery centers, we provide opportunities for over 30,000...

Continue reading

iCAD Announces Proposed Public Offering of Common Stock

NASHUA, N.H., March 02, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, the Company intends to grant the underwriters a thirty-day option to purchase up to an additional 15 percent of shares of its common stock offered in the public offering.Guggenheim Securities is acting as sole book-running manager for the offering.The Company intends to use...

Continue reading

NEP Group Acquires VISTA Worldlink, Expanding Centralized Production Capabilities in the US and Worldwide

PITTSBURGH, March 02, 2021 (GLOBE NEWSWIRE) —  NEP Group, the leading worldwide outsourced technical production partner for premier content producers of live sports and entertainment, announced that it has acquired VISTA Worldlink (“VISTA”), a pioneer in providing centralized broadcast solutions since 2017. The acquisition supports NEP’s strategic goal of becoming the worldwide leader in Centralized (Remote) Production.Founded by industry veteran Roy Liemer in 1988, VISTA provides end-to-end workflows, transmission and connectivity, and packaged traditional broadcast production solutions to customers in sports, entertainment, news, corporate and a range of other industries, covering thousands of events in North America each year as well as Europe.The broadcast industry is evolving, and NEP is evolving, too, to help content producers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.